0.90Open0.80Pre Close4.05K Volume4.02K Open Interest12.00Strike Price175.74KTurnover1469.75%IV0.41%PremiumJan 17, 2025Expiry Date0.17Intrinsic Value100Multiplier-2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.7414Delta1.1344Gamma54.09Leverage Ratio-50.5577Theta0.0000Rho40.10Eff Leverage0.0001Vega
CorMedix Stock Discussion
Until it wasn’t… Joe Todisco’s leadership, as CEO, troubles me.
CORMEDIX INC. ANNOUNCES PRELIMINARY FOURTH QUARTER 2024 RESULTS AND PROVIDES BUSINESS UPDATE - CorMedix | Prevention of cardiac, renal and infectious diseases
$72-78mm spending in 2025, “…largely driven by R&D,” they said?
“[Co...
Time to call it a day
No comment yet